'Serum alt' presentation slideshows

Hepatitis B

Hepatitis B. Review by Brent Whitworth, MD. Hepatitis B Virus. Hepatitis B virus (HBV) infection is a global public health problem. It is estimated that there are more than 350 million HBV carriers in the world, of whom 1 million will die annually from HBV-related liver disease.

796 views • 55 slides

Recognizing Drug-Induced Liver Injury (DILI) in Exposed Populations

Recognizing Drug-Induced Liver Injury (DILI) in Exposed Populations. John R. Senior, M.D. Associate Director for Science Office of Pharmacoepidemiology and Statistical Science Food and Drug Administration (FDA).

595 views • 48 slides

Peginterferon alfa-2b + Ribavirin versus Interferon alfa-2b + Ribavirin

293 views • 7 slides

Peginterferon alfa -2a+/- Ribavirin versus Interferon alfa-2b + Ribavirin

271 views • 6 slides

500

Supplemental Figure S1. 4000. BMP7-adeno. 3500. Control-adeno. Dark Cycle. 3000. B. DIO mice. C. DIO mice. 120. 250. 2500. N.S. N.S. 100. Ambulatory Counts. 2000. 200. 80. 1500. 150. Serum IL6 (pg/mL). Serum ALT (U/L). 60. 1000. 100. 40. 500. 50. 20. 0. 0:56. 2:10.

159 views • 4 slides